Mounjaro (tirzepatide) and Trulicity (dulaglutide) are prescription medications that help manage blood sugar levels in adults with type 2 diabetes. Though they work in slightly different ways ...

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.

Some Medicare plans may cover Trulicity for people with type 2 diabetes, but there will be some out-of-pocket costs. Learn more here.

Trulicity is a once-weekly injectable medication that people with type 2 diabetes may use to help maintain control of their blood sugar levels. Some Medicare Part D plans cover Trulicity.

The typical starting dosage of Trulicity for this use is 0.75 mg once per week. During treatment, your doctor will monitor your blood sugar levels. They may increase your dosage if needed to ...

The most commonly reported adverse events for people taking Trulicity were gastrointestinal-related and were consistent with prior Trulicity studies, including nausea (12%) and diarrhea (11.3%).

Trulicity and SGLT-2 drug combo doesn’t boost blood sugar loweringNew phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but ...